ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.13
-0.18%
Bitcoin
67,339.47
-1.20%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) News

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0J7G
DateTimeSourceHeadlineSymbolCompany
01/11/20242:00AMRNS Non-RegulatoryHutchmed (China) Limited Sovleplenib NDA Granted Priority Review in ChinaLSE:0J7GHutchison China Meditech Ltd
12/29/20233:30AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
12/29/20233:30AMUK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
12/21/20235:00AMUK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:0J7GHutchison China Meditech Ltd
12/13/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited Completed Enrollment of Phase II/III TrialLSE:0J7GHutchison China Meditech Ltd
12/13/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited Inclusion in National Reimbursement Drug ListLSE:0J7GHutchison China Meditech Ltd
12/07/20235:04AMUK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:0J7GHutchison China Meditech Ltd
12/01/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at CongressesLSE:0J7GHutchison China Meditech Ltd
11/30/20233:30AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
11/09/20232:00AMUK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)LSE:0J7GHutchison China Meditech Ltd
10/24/20234:30AMUK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPLSE:0J7GHutchison China Meditech Ltd
10/16/20234:30AMRNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO 2023LSE:0J7GHutchison China Meditech Ltd
09/29/20234:30AMRNS Non-RegulatoryHutchmed (China) Limited NDA Submission for Fruquintinib in JapanLSE:0J7GHutchison China Meditech Ltd
09/29/20234:30AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
09/14/20234:30AMUK RegulatoryHutchmed (China) Limited Director's Share DealingLSE:0J7GHutchison China Meditech Ltd
09/12/20234:30AMRNS Non-RegulatoryHutchmed (China) Limited Phase IIIb Savolitinib Results at WCLC 2023LSE:0J7GHutchison China Meditech Ltd
09/12/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited Patient Enrollment Completed for Bridging StudyLSE:0J7GHutchison China Meditech Ltd
08/31/20234:30AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
08/29/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited BTD in China for Savolitinib for Gastric CancerLSE:0J7GHutchison China Meditech Ltd
08/21/20232:00AMUK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointLSE:0J7GHutchison China Meditech Ltd
08/07/20234:30AMUK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorLSE:0J7GHutchison China Meditech Ltd
07/31/20237:00AMUK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
07/20/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for FruquintinibLSE:0J7GHutchison China Meditech Ltd
07/13/20234:30AMUK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeLSE:0J7GHutchison China Meditech Ltd
07/10/20232:00AMRNS Non-RegulatoryHutchmed (China) Limited Phase 1 Study of HMPL-415 InitiatedLSE:0J7GHutchison China Meditech Ltd
06/29/20234:30AMUK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
06/26/20234:30AMUK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
06/16/20232:00AMUK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetLSE:0J7GHutchison China Meditech Ltd
06/15/202310:39AMUK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMALSE:0J7GHutchison China Meditech Ltd
06/09/20235:30AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at EHA and ICMLLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
NSAV
Net Savings Link (PK)
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved